UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001668 |
|---|---|
| Receipt number | R000001978 |
| Scientific Title | Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801) |
| Date of disclosure of the study information | 2009/01/31 |
| Last modified on | 2015/07/29 22:20:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/01/29 23:20:58 | ||
| 2 | Update | 2009/02/02 08:55:19 | Recruitment status |
|
| 3 | Update | 2009/12/25 12:24:56 | Recruitment status |
|
| 4 | Update | 2010/06/08 18:48:24 | Recruitment status |
|
| 5 | Update | 2015/07/29 22:11:03 | Email Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 6 | Update | 2015/07/29 22:20:03 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results Results |
